MapLight officer proposes $97.6K stock sale

Kreitzer’s reported prior transactions occurred on July 15, July 16 and July 17, 2026.

Rhea-AI Filing Summary

MapLight Therapeutics, Inc. (MPLT) identifies Officer Anatol Kreitzer’s proposed sale of 12,500 shares of voting common stock, with an aggregate market value of $97,625.00, listed for October 15, 2026. The shares are described as restricted stock unit settlement, and the stated purpose is solely to satisfy tax-withholding obligations connected with vesting.

Key Figures

Proposed sale: 12,500 shares Aggregate market value: $97,625.00 Shares outstanding: 52,848,208 shares +2 more

5 metrics

Proposed sale 12,500 shares Voting common stock; listed for October 15, 2026

Aggregate market value $97,625.00 Proposed sale

Shares outstanding 52,848,208 shares Issuer share count reported in the notice

Prior sale 5,545 shares; $200,340.85 July 15, 2026

Prior sale 14,140 shares; $533,078.00 July 17, 2026

Key Terms

restricted stock unit settlement, tax-withholding obligations, voting common stock

3 terms

restricted stock unit settlement financial

"Restricted stock unit settlement"

tax-withholding obligations financial

"solely to satisfy tax-withholding obligations"

voting common stock technical

"MapLight voting common stock"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What prior MPLT sales did Anatol Kreitzer report?

Anatol Kreitzer reported seven sales of MapLight voting common stock: 5,545 shares for $200,340.85 and 4,510 shares for $166,599.40 on July 15, 2026; 7,464 shares for $273,630.24 and 1,592 shares for $59,604.48 on July 16, 2026; and 2,833 shares for $104,962.65, 14,140 shares for $533,078.00, and 200 shares for $7,678.00 on July 17, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/15/2026 - 04:09 PM EDT Accepted by SEC EDGAR 10/15/2026 - 04:09 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002021238
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	MapLight Therapeutics, Inc.
SEC File Number	001-42914
Address of Issuer	800 Chesapeake Drive Redwood City CALIFORNIA 94063
Phone	(617)-984-6300
Name of Person for Whose Account the Securities are To Be Sold	Anatol Kreitzer
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
MapLight voting common stock	Morgan Stanley Smith Barney LLC 1 New York Plaza 8th Floor New York NY 10004	12500	97625.00	52848208	10/15/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
MapLight voting common stock	10/15/2026	Restricted stock unit settlement	MapLight Therapeutics, Inc.			12500	10/15/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Anatol Kreitzer 800 Chesapeake Drive Redwood City CA 94063	MapLight voting common stock	07/15/2026	5545	200340.85
Anatol Kreitzer 800 Chesapeake Drive Redwood City CA 94063	MapLight voting common stock	07/15/2026	4510	166599.40
Anatol Kreitzer 800 Chesapeake Drive Redwood City CA 94063	MapLight voting common stock	07/16/2026	7464	273630.24
Anatol Kreitzer 800 Chesapeake Drive Redwood City CA 94063	MapLight voting common stock	07/16/2026	1592	59604.48
Anatol Kreitzer 800 Chesapeake Drive Redwood City CA 94063	MapLight voting common stock	07/17/2026	2833	104962.65
Anatol Kreitzer 800 Chesapeake Drive Redwood City CA 94063	MapLight voting common stock	07/17/2026	14140	533078.00
Anatol Kreitzer 800 Chesapeake Drive Redwood City CA 94063	MapLight voting common stock	07/17/2026	200	7678.00

144: Remarks and Signature

Remarks	Shares to be sold solely to satisfy tax-withholding obligations in connection with restricted stock unit vesting.
Date of Notice	10/15/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Anatol Kreitzer
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)